David Back

18.3k citations
364 papers · 13.4k · 2 hit papers · h-index 60

Impact in

  • Virology top 0.05%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

    • HIV/AIDS drug development and treatment 244
    • HIV/AIDS Research and Interventions 64
    • HIV Research and Treatment 157

David Back

361 papers receiving 12.9k citations

David Back's Hit Papers

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications 2022 · 162 citations
1620+8+16Years since publication100200300400500

Peers

David Back
Comparison fields: 5 of 151
  • Virology 4.7k
  • Infectious Diseases 8.0k
  • Pharmacology 2.1k
  • Emergency Medicine 1.8k
  • Hepatology 1.1k
Replace David M. Burger with:
David M. Burger Netherlands
Saye Khoo United Kingdom
Angela D. M. Kashuba United States
Laurent A. Décosterd Switzerland
Catia Marzolini Switzerland
Tomáš Cihlář United States
Courtney V. Fletcher United States
Andrew Owen United Kingdom
Edward P. Acosta United States
Alwin D. R. Huitema Netherlands
David Back relative to David M. Burger Netherlands David M. Burger's profile →
Citations per field
00.5×2.7×
David M. Burger · 1×
Citations per year

Countries citing papers authored by David Back

Since Specialization
Citations

This map shows the geographic impact of David Back's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Back with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Back more than expected).

Fields of papers citing papers by David Back

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Back. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Back. The network helps show where David Back may publish in the future.

Co-authors

The 25 scholars most cited alongside David Back, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Back Line = papers co-authored together David Back links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 364 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
Hit paper breakdown →
2002535
2 1998299
3 1997281
4 1999224
5 1997216
6 1992212
7 2002198
8 2009194
9 1990168
10
Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
Hit paper breakdown →
2022162
11 2009161
12 1997159
13 2008147
14 2002147
15 1983147
16 2003141
17 2010138
18 1999137
19 2001123
20 2020121

About David Back

David Back is a scholar working on Infectious Diseases, Virology, Pediatrics, Perinatology and Child Health, Oncology and Pharmacology, having authored 364 papers that have together received 13.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (244 papers), HIV Research and Treatment (157 papers), Pharmacological Effects and Toxicity Studies (70 papers), HIV/AIDS Research and Interventions (64 papers), Drug Transport and Resistance Mechanisms (62 papers), HIV-related health complications and treatments (52 papers), Pharmacogenetics and Drug Metabolism (50 papers) and Hepatitis C virus research (41 papers). The work is most often cited by research in Virology (4.7k citations), Infectious Diseases (8.0k citations), Pharmacology (2.1k citations), Emergency Medicine (1.8k citations) and Hepatology (1.1k citations). David Back has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Saye Khoo, Michael Barry, Andrew Owen, Sara Gibbons, Michael Orme, John Tjia, Patrick G. Hoggard, Catia Marzolini, Marta Boffito and Fiona Mulcahy. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antiviral Therapy, AIDS, Antimicrobial Agents and Chemotherapy and British Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact